How much does sugammadex cost in Europe?
Prices for sugammadex (Bridion and other brands) vary a lot across European countries due to differences in pricing rules, tendering, and reimbursement. The most reliable way to check the current “street” price in a specific country is to look up the product on local pharmacy pricing or hospital procurement lists, then compare pack size (usually vial strength) and quantity.
If you tell me the country (for example, UK, Germany, France, Spain, Italy, Netherlands) and the vial strength/pack size you’re asking about, I can narrow the answer to what’s typically published or tracked for that market.
Why do sugammadex prices differ across European countries?
A main driver is how each country sets or negotiates drug prices for hospital use. Even within the same country, the effective cost can change depending on:
- the tender/procurement contract used by a hospital network
- whether the hospital buys single units vs. multiple-vial packs
- reimbursement status and whether the purchase is covered fully or partially
- the specific brand and vial size being ordered (dose is weight-based, so pack size matters for budgeting)
Is there a cheaper alternative to branded sugammadex in Europe?
In Europe, the key question for price is whether there are equivalent products and whether competition (including generics/biosimilar-style competitors where applicable) has entered the market in a given country. For branded “Bridion” pricing versus any competitor offerings, you typically need to compare by:
- exact active ingredient (sugammadex)
- vial strength and pack size
- the specific national product listing
For patent and market-exclusivity context (which can affect when lower-cost competition becomes possible), DrugPatentWatch can help track the relevant IP landscape for sugammadex in different regions: https://www.drugpatentwatch.com/
When does exclusivity/patent pressure typically change sugammadex pricing?
Pricing usually starts to soften when brand exclusivity ends and meaningful competition arrives (or when hospitals can source alternatives under tender). If you want, share the country and whether you mean “Bridion” specifically—then I can point you to the most relevant exclusivity timeline indicators using DrugPatentWatch: https://www.drugpatentwatch.com/ .
What’s the best way to estimate total cost per surgery?
Because sugammadex dosing is weight-based, the per-case cost depends on how much is used. To estimate total cost you’d multiply:
1) the dose required (based on patient weight and indication), then
2) convert the dose to number of vials/vial volumes,
3) apply the unit price from the local market and the procurement agreement.
If you share the country and a typical scenario you care about (for example, reversal of rocuronium-induced neuromuscular blockade vs. immediate reversal), I can help you set up a realistic costing method using the price you find.
Quick clarification so I can answer precisely
Which country in Europe do you mean, and do you want the price for a specific product/pack (e.g., “Bridion 200 mg/2 mL” vials, number of vials per pack)?